Adocia S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ADOCY research report →
Price Chart
About the company
Adocia S. A. is a clinical-stage biotechnology company dedicated to the research and development of novel formulations of established therapeutic proteins and peptides.
- CEO
- Olivier Soula
- IPO
- 2014
- Employees
- 78
- HQ
- Lyon, FR
Get TickerSpark's AI analysis on ADOCY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $170.44M
- P/E
- -2.50
- Fwd P/E
- 70.73
- PEG
- 0.05
- P/S
- -59.52
- P/B
- -8.75
- EV/EBITDA
- -2.50
- Div Yield
- 0.00%
- Gross Margin
- 2703.38%
- Op Margin
- 2707.93%
- Net Margin
- 2334.21%
- ROE
- 1026.21%
- ROIC
- -346.90%
Latest fiscal year · YoY change
- Revenue
- $1.42M-84.8%
- Gross Profit
- $0-100.0%
- Op Income
- $-17,421,181
- Net Income
- $-15,936,197-71.0%
- EPS
- $-0.81-22.7%
- OCF Growth
- +59.8%
- FCF Growth
- +58.8%
- 52W High
- $11.80
- 52W Low
- $11.80
- 50D MA
- $11.80
- 200D MA
- $11.80
- Beta
- 0.86
- RSI (14)
- 100
- Avg Volume
- 112
No earnings-call transcripts are available for ADOCY yet.
- Free Float
- 73.0%
- Shares Outstanding
- 14.44M
- Float Shares
- 10.54M
Our ADOCY coverage
Recent articles, reports, and earnings notes.
No research on ADOCY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ADOCY report →